Robert M Plenge - Net Worth and Insider Trading

Robert M Plenge Net Worth

The estimated net worth of Robert M Plenge is at least $304,262 dollars as of 2024-04-27. Robert M Plenge is the EVP, Chief Research Officer of Bristol-Myers Squibb Co and owns about 6,784 shares of Bristol-Myers Squibb Co (BMY) stock worth over $304,262. Details can be seen in Robert M Plenge's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robert M Plenge has not made any transactions after 2023-08-03 and currently still holds the listed stock(s).

Transaction Summary of Robert M Plenge

To

Robert M Plenge Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert M Plenge owns 2 companies in total, including Translate Bio Inc (TBIO) , and Bristol-Myers Squibb Co (BMY) .

Click here to see the complete history of Robert M Plenge’s form 4 insider trades.

Insider Ownership Summary of Robert M Plenge

Ticker Comapny Transaction Date Type of Owner
TBIO Translate Bio Inc 2020-06-16 director
BMY Bristol-Myers Squibb Co 2023-08-03 EVP & Chief Research Officer

Robert M Plenge Latest Holdings Summary

Robert M Plenge currently owns a total of 1 stock. Robert M Plenge owns 6,784 shares of Bristol-Myers Squibb Co (BMY) as of August 3, 2023, with a value of $304,262.

Latest Holdings of Robert M Plenge

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BMY Bristol-Myers Squibb Co 2023-08-03 6,784 44.85 304,262

Holding Weightings of Robert M Plenge


Robert M Plenge Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert M Plenge has made a total of 1 transactions in Bristol-Myers Squibb Co (BMY) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Bristol-Myers Squibb Co is the sale of 732 shares on August 3, 2023, which brought Robert M Plenge around $44,755.

Insider Trading History of Robert M Plenge

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert M Plenge Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Robert M Plenge Ownership Network

Ownership Network List of Robert M Plenge

No Data

Ownership Network Relation of Robert M Plenge


Robert M Plenge Owned Company Details

What does Translate Bio Inc do?

Who are the key executives at Translate Bio Inc?

Robert M Plenge is the director of Translate Bio Inc. Other key executives at Translate Bio Inc include director & Chief Executive Officer & other: President Renaud Ronald C Jr , Chief Operating Officer & CLO & other: Secretary Paul D. Burgess , and 10 percent owner Shire Human Genetic Therapies, Inc. .

Translate Bio Inc (TBIO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Translate Bio Inc (TBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Translate Bio Inc (TBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Translate Bio Inc (TBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Translate Bio Inc Insider Transactions

No Available Data

Robert M Plenge Mailing Address

Above is the net worth, insider trading, and ownership report for Robert M Plenge. You might contact Robert M Plenge via mailing address: C/o Translate Bio, Inc., 29 Hartwell Avenue, Lexington Ma 02421.

Discussions on Robert M Plenge

No discussions yet.